1. Enzyme therapy is not enough
Prof Gregory A Grabowski, MD 
The Lancet 
Volume 358, (December 2001)
DOI: /S (01)
Copyright © 2001 Elsevier Ltd Terms and Conditions

2. Figure
Schematic diagram of glucocerebroside synthesis and degradative pathways The O-series, A-series, and B-series of higher glucosphingolipids comprise over 300 compounds. Newly synthesised glucocerebroside products incorporate into cellular membranes and extracellular structures. In the viscera, these cellular components are internalised and delivered to the lysosomes for degradation. Lac=lactosylceramide; cer=ceramide; GalNAcT=N-acetyl-galactosaminyl-transferase; glc=glucose.
The Lancet  , DOI: ( /S (01) )
Copyright © 2001 Elsevier Ltd Terms and Conditions

3. The Lancet 2001 358, DOI: (10.1016/S0140-6736(01)07042-8)
Copyright © 2001 Elsevier Ltd Terms and Conditions